222 related articles for article (PubMed ID: 31703613)
1. PSMD1 and PSMD2 regulate HepG2 cell proliferation and apoptosis via modulating cellular lipid droplet metabolism.
Tan Y; Jin Y; Wu X; Ren Z
BMC Mol Biol; 2019 Nov; 20(1):24. PubMed ID: 31703613
[TBL] [Abstract][Full Text] [Related]
2. ATG16 mediates the autophagic degradation of the 19S proteasomal subunits PSMD1 and PSMD2.
Xiong Q; Fischer S; Karow M; Müller R; Meßling S; Eichinger L
Eur J Cell Biol; 2018 Nov; 97(8):523-532. PubMed ID: 30269947
[TBL] [Abstract][Full Text] [Related]
3. PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation.
Li Y; Huang J; Zeng B; Yang D; Sun J; Yin X; Lu M; Qiu Z; Peng W; Xiang T; Li H; Ren G
Cancer Lett; 2018 Aug; 430():109-122. PubMed ID: 29777785
[TBL] [Abstract][Full Text] [Related]
4. Proteasomal non-catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas.
Matsuyama Y; Suzuki M; Arima C; Huang QM; Tomida S; Takeuchi T; Sugiyama R; Itoh Y; Yatabe Y; Goto H; Takahashi T
Mol Carcinog; 2011 Apr; 50(4):301-9. PubMed ID: 21465578
[TBL] [Abstract][Full Text] [Related]
5. Asporin promotes cell proliferation via interacting with PSMD2 in gastric cancer.
Zhang Z; Li H; Zhao Y; Guo Q; Yu Y; Zhu S; Zhang S; Min L; Li P
Front Biosci (Landmark Ed); 2019 Jun; 24(6):1178-1189. PubMed ID: 31136974
[TBL] [Abstract][Full Text] [Related]
6. Depletion of proteasome subunit PSMD1 induces cancer cell death via protein ubiquitination and DNA damage, irrespective of p53 status.
Kim MY; Park ER; Cho EH; Park SH; Han CJ; Kim SB; Gu MB; Shin HJ; Lee KH
Sci Rep; 2024 Apr; 14(1):7997. PubMed ID: 38580756
[TBL] [Abstract][Full Text] [Related]
7. Proteasome 26S subunit, non-ATPase 1 (PSMD1) facilitated the progression of lung adenocarcinoma by the de-ubiquitination and stability of PTEN-induced kinase 1 (PINK1).
Liu L; Liu A; Dong J; Zuo Z; Liu X
Exp Cell Res; 2022 Apr; 413(2):113075. PubMed ID: 35192838
[TBL] [Abstract][Full Text] [Related]
8. PSMD2 contributes to the progression of esophageal squamous cell carcinoma by repressing autophagy.
Liu Y; Wu M; Xu S; Niu X; Liu W; Miao C; Lin A; Xu Y; Yu L
Cell Biosci; 2023 Mar; 13(1):67. PubMed ID: 36998052
[TBL] [Abstract][Full Text] [Related]
9. 26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy.
Rubio AJ; Bencomo-Alvarez AE; Young JE; Velazquez VV; Lara JJ; Gonzalez MA; Eiring AM
Cells; 2021 Sep; 10(9):. PubMed ID: 34572038
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Significance of Proteasome 26S Subunit, Non-ATPase (PSMD) Genes for Bladder Urothelial Carcinoma Patients.
Salah Fararjeh A; Al-Khader A; Al-Saleem M; Abu Qauod R
Cancer Inform; 2021; 20():11769351211067692. PubMed ID: 34992336
[TBL] [Abstract][Full Text] [Related]
11. Bergapten inhibits liver carcinogenesis by modulating LXR/PI3K/Akt and IDOL/LDLR pathways.
Pattanayak SP; Bose P; Sunita P; Siddique MUM; Lapenna A
Biomed Pharmacother; 2018 Dec; 108():297-308. PubMed ID: 30227322
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
13. Proteasome 26S subunit PSMD1 regulates breast cancer cell growth through p53 protein degradation.
Okumura T; Ikeda K; Ujihira T; Okamoto K; Horie-Inoue K; Takeda S; Inoue S
J Biochem; 2018 Jan; 163(1):19-29. PubMed ID: 28992264
[TBL] [Abstract][Full Text] [Related]
14. Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma.
Jiang Z; Zhou Q; Ge C; Yang J; Li H; Chen T; Xie H; Cui Y; Shao M; Li J; Tian H
Cancer Lett; 2019 Apr; 447():1-11. PubMed ID: 30673593
[TBL] [Abstract][Full Text] [Related]
15. Reactive Oxygen Species Induces Lipid Droplet Accumulation in HepG2 Cells by Increasing Perilipin 2 Expression.
Jin Y; Tan Y; Chen L; Liu Y; Ren Z
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400205
[TBL] [Abstract][Full Text] [Related]
16. Depleting the 19S proteasome regulatory PSMD1 subunit as a cancer therapy strategy.
Adler J; Oren R; Shaul Y
Cancer Med; 2023 May; 12(9):10781-10790. PubMed ID: 36934426
[TBL] [Abstract][Full Text] [Related]
17. Lactoferrin attenuates fatty acid-induced lipotoxicity via Akt signaling in hepatocarcinoma cells.
Morishita S; Tomita K; Ono T; Murakoshi M; Saito K; Sugiyama K; Nishino H; Kato H
Biochem Cell Biol; 2015 Dec; 93(6):566-73. PubMed ID: 26335364
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibition sensitizes hepatocellular carcinoma cells to TRAIL by suppressing caspase inhibitors and AKT pathway.
Inoue T; Shiraki K; Fuke H; Yamanaka Y; Miyashita K; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Anticancer Drugs; 2006 Mar; 17(3):261-8. PubMed ID: 16520654
[TBL] [Abstract][Full Text] [Related]
19. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
20. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
